• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别与克服晶体病理学:无序与孪晶

Identifying and Overcoming Crystal Pathologies: Disorder and Twinning.

作者信息

Thompson Michael C

机构信息

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, Box 2240, 600 16th Street, S476, San Francisco, CA, 94158, USA.

出版信息

Methods Mol Biol. 2017;1607:185-217. doi: 10.1007/978-1-4939-7000-1_8.

DOI:10.1007/978-1-4939-7000-1_8
PMID:28573574
Abstract

Macromolecular crystals are prone to a number of pathologies that result from aberrant molecular packing. Two common pathologies encountered in macromolecular crystals are rigid-body disorder and twinning. When a crystal displays one of these pathologies, its diffraction pattern is altered in a way that generally complicates structure determination. The severity of the underlying abnormalities varies from case to case, and sometimes the resulting alterations to the diffraction pattern are immediately obvious, while at other times they may go entirely unnoticed. Structure determination from a crystal that suffers from disorder or twinning may or may not be possible, depending on the specific nature of the pathology, and on how the data are handled. This chapter provides an introduction to these pathologies, with an emphasis on providing guidelines for identifying and overcoming them when they pose a threat to successful structure determination.

摘要

大分子晶体容易出现许多由异常分子堆积导致的病理现象。大分子晶体中常见的两种病理现象是刚体无序和孪晶。当晶体出现这些病理现象之一时,其衍射图样会发生改变,这通常会使结构测定变得复杂。潜在异常的严重程度因情况而异,有时对衍射图样产生的改变会立即显现出来,而在其他时候可能完全不被注意到。根据病理现象的具体性质以及数据处理方式,从患有无序或孪晶的晶体中进行结构测定可能可行,也可能不可行。本章介绍这些病理现象,重点是提供在它们对成功的结构测定构成威胁时识别和克服它们的指导原则。

相似文献

1
Identifying and Overcoming Crystal Pathologies: Disorder and Twinning.识别与克服晶体病理学:无序与孪晶
Methods Mol Biol. 2017;1607:185-217. doi: 10.1007/978-1-4939-7000-1_8.
2
Collection of X-Ray Diffraction Data from Macromolecular Crystals.从大分子晶体收集X射线衍射数据。
Methods Mol Biol. 2017;1607:165-184. doi: 10.1007/978-1-4939-7000-1_7.
3
Applications of X-Ray Micro-Beam for Data Collection.用于数据收集的X射线微束应用。
Methods Mol Biol. 2017;1607:219-238. doi: 10.1007/978-1-4939-7000-1_9.
4
Serial Synchrotron X-Ray Crystallography (SSX).连续同步辐射X射线晶体学(SSX)
Methods Mol Biol. 2017;1607:239-272. doi: 10.1007/978-1-4939-7000-1_10.
5
Crystal pathologies in macromolecular crystallography.大分子晶体学中的晶体病理学
Postepy Biochem. 2016;62(3):401-407.
6
Intensity statistics in twinned crystals with examples from the PDB.孪晶中的强度统计及来自蛋白质数据库的示例
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):83-95. doi: 10.1107/S0907444905036759. Epub 2005 Dec 14.
7
Processing of XFEL Data.X射线自由电子激光数据处理
Methods Mol Biol. 2017;1607:325-347. doi: 10.1007/978-1-4939-7000-1_13.
8
Pathological crystallography: case studies of several unusual macromolecular crystals.病理晶体学:几种异常大分子晶体的案例研究。
Acta Crystallogr D Biol Crystallogr. 2005 Jul;61(Pt 7):967-75. doi: 10.1107/S0907444905011285. Epub 2005 Jun 24.
9
Locating and Visualizing Crystals for X-Ray Diffraction Experiments.用于X射线衍射实验的晶体定位与可视化
Methods Mol Biol. 2017;1607:143-164. doi: 10.1007/978-1-4939-7000-1_6.
10
Detecting and overcoming crystal twinning.检测并克服晶体孪晶。
Methods Enzymol. 1997;276:344-58.

引用本文的文献

1
Crystal structure of the second extracellular domain of human tetraspanin CD9: twinning and diffuse scattering.人四跨膜蛋白CD9第二个胞外结构域的晶体结构:孪晶与漫散射
IUCrdata. 2022 Sep 23;7(Pt 9):x220852. doi: 10.1107/S2414314622008525. eCollection 2022 Sep.
2
Computational design of a modular protein sense-response system.模块化蛋白感应反应系统的计算设计。
Science. 2019 Nov 22;366(6468):1024-1028. doi: 10.1126/science.aax8780.
3
Never too late for endothelin.内皮素治疗永远不会太晚。
Acta Crystallogr F Struct Biol Commun. 2019 Jan 1;75(Pt 1):45-46. doi: 10.1107/S2053230X18018101.